Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vascular

Explore clinical trials studying Skin Diseases, Vascular. Study availability and eligibility vary by location and protocol.

953 public trials 192 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vascular trial results

Active, Not Recruiting

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT06445023

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Cahaba Dermatology Skin Health Center Birmingham, Alabama, United States
  • First OC Dermatology - Fountain Valley Fountain Valley, California, United States
  • 310 Clinical Research Inglewood, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 235 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

NCT06455202

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research - Cullman Cullman, Alabama, United States
  • Research Solutions of Arizona PC Litchfield Park, Arizona, United States
  • Medical Research of Arizona a division of Allergy, Asthma, & Immunology, Assoc. Ltd. Scottsdale, Arizona, United States
  • Center for Dermatology & Plastic Surgery Scottsdale, Arizona, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

NCT05120830

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Trial Site Campbelltown, Australia
  • Clinical Trial Site Grenoble, France
  • Clinical Trial Site Lille, France
  • Clinical Trial Site Paris, France
View Trial Details
Active, Not Recruiting

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

NCT03323476

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +22 more
Locations
  • Centre Hospitalier Universitaire Amiens Amiens, France
  • CHU Angers Angers, France
  • Centre Hospitalier Angoulême Angoulême, France
  • Centre Hospitalier ARRAS Arras, France
View all 57 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

NCT05513001

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Acuro Research Inc Little Rock, Arkansas, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)

NCT04161898

Conditions
Aortic Arch Syndromes, Aortic Diseases, Arteritis, +8 more
Locations
  • Fundación Sanatorio Guemes /ID# 249675 Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
  • Hospital Italiano La Plata /ID# 249269 La Plata, Buenos Aires, Argentina
  • SER - Servicos Especializados em Reumatologia da Bahia /ID# 243125 Salvador, Estado de Bahia, Brazil
  • CMiP - Centro Mineiro de Pesquisa Ltda - ME /ID# 242517 Juiz de Fora, Minas Gerais, Brazil
View all 48 locations
View Trial Details

Related conditions